- Home
- JCTC vs HOTH Comparison
JCTC vs HOTH Comparison
Compare JCTC & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCTC
- HOTH
- Stock Information
- Founded
- JCTC 1953
- HOTH 2017
- Country
- JCTC United States
- HOTH United States
- Employees
- JCTC N/A
- HOTH N/A
- Industry
- JCTC
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- JCTC
- HOTH Health Care
- Exchange
- JCTC NYSE
- HOTH Nasdaq
- Market Cap
- JCTC 13.2M
- HOTH 15.6M
- IPO Year
- JCTC 1996
- HOTH 2019
- Fundamental
- Price
- JCTC $3.49
- HOTH $1.35
- Analyst Decision
- JCTC
- HOTH Strong Buy
- Analyst Count
- JCTC 0
- HOTH 3
- Target Price
- JCTC N/A
- HOTH $4.00
- AVG Volume (30 Days)
- JCTC 16.7K
- HOTH 429.0K
- Earning Date
- JCTC 07-14-2025
- HOTH 05-12-2025
- Dividend Yield
- JCTC N/A
- HOTH N/A
- EPS Growth
- JCTC N/A
- HOTH N/A
- EPS
- JCTC N/A
- HOTH N/A
- Revenue
- JCTC $44,141,421.00
- HOTH N/A
- Revenue This Year
- JCTC N/A
- HOTH N/A
- Revenue Next Year
- JCTC N/A
- HOTH N/A
- P/E Ratio
- JCTC N/A
- HOTH N/A
- Revenue Growth
- JCTC N/A
- HOTH N/A
- 52 Week Low
- JCTC $3.26
- HOTH $0.58
- 52 Week High
- JCTC $5.41
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- JCTC N/A
- HOTH 55.25
- Support Level
- JCTC N/A
- HOTH $1.21
- Resistance Level
- JCTC N/A
- HOTH $1.36
- Average True Range (ATR)
- JCTC 0.00
- HOTH 0.11
- MACD
- JCTC 0.00
- HOTH -0.01
- Stochastic Oscillator
- JCTC 0.00
- HOTH 38.89
About JCTC JEWETT-CAMERON TRADING CO
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).